BPIFB4 and atherosclerosis: In experimental studies, researchers observed that administration of the BPIFB4 protein encoded by the LAV-BPIFB4 gene to the human blood vessels of patients with atherosclerosis resulted in improved vascular activity, reduced blood pressure, and increased resistance to cellular stress.